Pituitary Gland

Pituitary Gland

Overview and Definition

Often referred to as the "master gland," the pituitary gland synthesizes and releases various hormones that affect several organs throughout the body. It is the master gland of the endocrine system — an ovoid-shaped structure located in the sella turcica of the sphenoid bone. It sits at the base of the brain, behind the bridge of the nose, and measures about one-half inch (1.25 cm) in diameter.

The pituitary gland is an endocrine gland that works to maintain cellular homeostasis in the body by the release of different hormones. It is also called the master gland, as it regulates the working and secretion of other endocrine glands. Even though the pituitary gland is the most important endocrine gland, it remains regulated by the secretions of the hypothalamus. The pituitary gland is attached to the hypothalamus of the brain by a single stalk called the infundibulum.

Anatomy and Structure

Location and Enclosure

In humans, the pituitary gland rests upon the hypophyseal fossa of the sphenoid bone, in the center of the middle cranial fossa. It sits in a protective bony enclosure called the sella turcica, covered by a fold of dura mater known as the diaphragma sellae. The pituitary gland sits below the optic chiasm — the point where the fibers of the optic nerves cross each other — and between the internal carotid arteries.

Lobes and Embryological Origin

The pituitary gland is entirely ectodermal in origin but is composed of two functionally distinct structures that differ in embryologic development and anatomy: the adenohypophysis (anterior pituitary) and the neurohypophysis (posterior pituitary). The posterior pituitary (neurohypophysis) is neural tissue, whereas the anterior pituitary (also known as the adenohypophysis) is glandular tissue that develops from the primitive digestive tract.

The pituitary gland is composed of the anterior pituitary, the posterior pituitary, and an intermediate lobe that joins them. The intermediate lobe is avascular and almost absent in humans, but in many other animals it is distinct.

Vasculature

The adenohypophysis and neurohypophysis receive the majority of their blood supply from superior hypophyseal arteries and inferior hypophyseal arteries, respectively. Venous drainage for both lobes occurs via anterior and posterior hypophyseal veins, which empty into the cavernous sinus.

Physiological Functions and Hormones

General Role

Hormones secreted from the pituitary gland help to control growth, blood pressure, energy management, all functions of the sex organs, thyroid gland, metabolism, as well as some aspects of pregnancy, childbirth, breastfeeding, water/salt concentration at the kidneys, temperature regulation, and pain relief.

The hypothalamus–pituitary complex can be thought of as the "command center" of the endocrine system. This complex secretes several hormones that directly produce responses in target tissues, as well as hormones that regulate the synthesis and secretion of hormones of other glands. In addition, the hypothalamus–pituitary complex coordinates the messages of the endocrine and nervous systems.

Anterior Pituitary (Adenohypophysis) Hormones

The anterior pituitary secretes growth hormone (GH), thyroid stimulating hormone (TSH), adrenocorticotrophic hormone (ACTH), luteinizing hormone (LH), follicle stimulating hormone (FSH), and prolactin. The anterior pituitary's secretory activity is regulated by hypothalamic releasing and inhibiting hormones delivered through the hypophyseal portal system.

• Growth Hormone (GH): Stimulates somatic growth and cell repair throughout the body.
• Thyroid Stimulating Hormone (TSH): Directs the thyroid gland to produce thyroid hormones, which regulate metabolism.
• Adrenocorticotrophic Hormone (ACTH): ACTH stimulates the adrenal glands to secrete cortisol, the steroid that controls blood pressure and tonicity of the arterial wall. Lack of ACTH is associated with low serum cortisol and hypotension, especially during stressful situations such as high fever, accidents, operations, and anesthesia.
• Luteinizing Hormone (LH) and Follicle Stimulating Hormone (FSH): Regulate reproductive function in both sexes, including ovulation, spermatogenesis, and sex hormone production.
• Prolactin: Stimulates milk production in the mammary glands.

Posterior Pituitary (Neurohypophysis) Hormones

Vasopressin and oxytocin are the two hormones released from the posterior pituitary. These hormones are produced in the hypothalamus and transported to the posterior pituitary for storage and release.

• Antidiuretic Hormone (ADH/Vasopressin): This hormone regulates the water balance and sodium levels in the body.
• Oxytocin: Oxytocin helps labor to progress during childbirth by sending signals to the uterus to contract. It also causes breast milk to flow and influences the bonding between parent and baby, and also plays a role in moving sperm.

Feedback Regulation

The pituitary gland's activity is tightly controlled by the hypothalamus through neural and vascular connections via the infundibulum (pituitary stalk). There are two negative feedback loops that affect the hypothalamic-pituitary axis. In the long-loop feedback, when the blood level of hormones from the peripheral glands reaches the homeostatic/physiological value, those hormones signal to the pituitary and hypothalamus to stop the secretion of releasing and stimulating hormones. In the short-loop feedback, the rise of pituitary hormone blood levels inhibits the synthesis and/or release of the related hypothalamic hormones.

Assessment of Pituitary Health

Hormonal Blood and Urine Testing

Hormone blood tests measure the levels of specific hormones produced by the pituitary gland, such as ACTH, TSH, LH, follicle-stimulating hormone (FSH), growth hormone (GH), and prolactin. Tests often include checking levels of growth hormone (GH and IGF-1), reproductive hormones (estradiol, testosterone, FSH, LH), prolactin, thyroid hormones (TSH and free T4), ACTH, and cortisol for assessing adrenal function, in addition to other basic labs.

Blood tests to check levels of hormones, blood sugar, and other substances, urine tests to determine levels of certain hormones, and venous sampling — in which a sample of blood is taken from veins coming from the pituitary gland — are all used diagnostically.

Dynamic Endocrine (Stimulation) Testing

Dynamic endocrine testing involves the administration of substances (e.g., insulin, corticotropin-releasing hormone, or growth hormone-releasing hormone) to stimulate the release of pituitary hormones. The response to stimulation helps assess pituitary function. Inferior petrosal sinus sampling (IPSS) may be used if an MRI of the head does not clearly show a pituitary tumor. Catheters are guided up into the petrosal sinuses, small veins near the pituitary. An injection that causes the pituitary to make more ACTH is typically given, and blood samples are taken before and after the injection. These samples are tested to see if the ACTH level is higher in the blood from the pituitary — if so, the source of the high ACTH level is very likely a pituitary tumor.

Imaging

Imaging tests, such as magnetic resonance imaging (MRI), can visualize the pituitary gland and detect tumors or structural abnormalities that may affect hormone production. An optimal assessment of sellar and suprasellar mass lesions requires both non-contrast and gadolinium-enhanced MRI imaging. Pituitary CT scanning is less sensitive than MRI for the detection of pituitary adenomas and is usually reserved for those patients who cannot safely undergo brain MRI.

Sagittal plane MRI images allow assessment of the pituitary, the stalk, the infundibulum, and the optic chiasm. T2 weighted images, in combination with Fluid Attenuation Inversion Recovery (FLAIR) sequences, can reliably characterize an empty sella without the need for intravenous contrast.

Conditions and Disorders of the Pituitary Gland

With pituitary disorders, you often have too much or too little of one of your hormones. Injuries can cause pituitary disorders, but the most common cause is a pituitary tumor. Pituitary disorders often develop slowly. It may take a long time until you notice symptoms. Symptoms of pituitary disorders are similar to those of other diseases, and many people are misdiagnosed or go undiagnosed.

Pituitary Adenoma (Pituitary Tumor)

One of the most common diseases associated with the pituitary gland is a pituitary adenoma. In this condition, tumors are observed in the sellar region of the gland. The tumors are classified as microadenomas (size less than 10 mm) and macroadenomas (size more than 10 mm). The larger tumors can compress other organs of the area, which might create other severe conditions. Pituitary problems can be caused by pituitary tumors, most of which are benign. Because of the location of the pituitary gland, large pituitary tumors can press against the optic nerves, causing vision problems.

Acromegaly

Acromegaly occurs when a pituitary tumor produces excess growth hormones. More than 95% of acromegaly cases are caused by benign tumors on the pituitary gland.

Cushing's Disease

Cushing's syndrome occurs when a pituitary tumor produces an excessive amount of a hormone called ACTH, which elevates blood cortisol levels. About 10 to 15 people per million are diagnosed with Cushing disease/syndrome, caused by too much cortisol, each year in the U.S. ACTH-secreting tumors, also known as Cushing's disease, can be particularly difficult to diagnose and may require additional diagnostic tests.

Hypopituitarism

Hypopituitarism is a medical condition characterized by insufficient hormone production in the pituitary gland. The association between hypopituitarism and increased mortality due to elevated cardiovascular and respiratory diseases highlights the crucial need for early detection. Hypopituitarism denotes either complete or partial deficiency of pituitary hormones. The etiologies that lead to hypopituitarism are classified as congenital, neoplastic, and inflammatory diseases. Hypopituitarism, also called an underactive pituitary gland, affects the function of the anterior lobe of the pituitary gland and can impact hormone production in the adrenals, thyroid, testes, or ovaries.

Prolactinoma

The common pituitary disorders in endocrine practice include prolactinoma, acromegaly, Cushing's disease, non-functional pituitary adenoma (NFPA), and hypopituitarism. Prolactinoma is the most common type of secreting pituitary adenoma, characterized by excess prolactin secretion, which can result in disrupted reproductive function, galactorrhea, and infertility.

Arginine Vasopressin (AVP) Disorders

Arginine vasopressin (AVP, also known as antidiuretic hormone or ADH) is a hormone that plays a crucial role in regulating the body's water balance, blood pressure, and urine production. AVP is made in the hypothalamus, and it is stored and released by the posterior pituitary gland. AVP disorders, especially AVP insufficiency and excess, can often be related to issues with the pituitary function.

Empty Sella Syndrome

Empty Sella syndrome is a rare disorder characterized by the enlargement or malformation of the sella turcica, resulting in a herniation of the arachnoid membrane into the pituitary fossa. This displacement pushes the pituitary gland toward the floor of the fossa, potentially resulting in a smaller or absent pituitary gland. Empty Sella syndrome may be idiopathic or secondary to factors such as treated pituitary tumors, head trauma, or a condition called pseudotumor cerebri.

Kallmann Syndrome

Kallmann syndrome is a rare genetic condition characterized by an inability to detect odor (hyposmia or anosmia) and hypogonadotropic hypogonadism, marked by decreased FSH, LH, testosterone, or estradiol.

Nutrients Supporting Pituitary and Hypothalamic-Pituitary Axis Function

The following section distinguishes between documented physiological roles of nutrients (established science) and their studied effects in human or animal populations. No marketing claims are made, and evidence strength is characterized honestly throughout.

Vitamin D

Scientific Evidence:

Vitamin D receptor (VDR) expression levels throughout the body are quite variable. Interestingly, VDRs are found in pituitary tissue. Vitamin D levels might impact hypophyseal production or activity of hormones such as growth hormone, gonadotropins (follicle-stimulating hormone, luteinizing hormone), prolactin, corticotropin, and thyroid-stimulating hormone (TSH).

Researchers have demonstrated VDR mRNA expression using reverse transcription-polymerase chain reaction (RT-PCR), as well as the cellular expression of VDR by immunohistochemistry, both in the human pituitary gland. These results suggest the possibility that, like in the rat pituitary, VDR may regulate human pituitary gene expression and hormone secretion.

In autoradiographic studies, thyrotropes showed strong and extensive nuclear concentration of radioactivity — about 90% of the immunostained thyrotropes were labeled. Lactotropes, somatotropes, and gonadotropes showed no or only weak nuclear radioactivity. The results indicate a presence of nuclear receptors for 1,25(OH)₂ vitamin D3 in pituitary cell types and suggest direct but differential genomic effects on pituitary hormone secretion. Evidence further suggests the existence of a vitamin D-regulated brain-pituitary-thyroid axis.

Several recent clinical and laboratory studies documenting either subfertility or frank infertility in vitamin D3 deficient states suggest that vitamin D3 may be essential for normal reproductive physiology and reproductive success. The mechanisms by which vitamin D3 regulates the hypothalamic-pituitary-gonadal axis and how vitamin D3 deficiency adversely affects female fertility and reproduction are not yet fully understood.

Evidence level: Preclinical, molecular, and some observational human data exist. Direct clinical trials targeting vitamin D supplementation and measurable pituitary hormone change are limited. No robust clinical trials have established a causal therapeutic benefit of vitamin D supplementation on pituitary function in otherwise replete individuals.

Vitamin A (Retinol and Retinoic Acid)

Scientific Evidence:

In order to gain a better understanding of the possible role of vitamin A (VA) and retinoic acid (RA) on human growth hormone (GH) secretion, researchers used the physiological model of pituitary cells perifusion. In perifused cells from pituitary somatotropic adenomas, RA induced within minutes a peak of GH secretion. This effect was dose dependent, with the maximal effect observed with 100 nM. The GH release was associated with a discharge of cAMP. Similar results were obtained after VA stimulation. These observations provide the first evidence of an action of VA and RA on cAMP production and suggest a role of RA and VA in the regulation of human GH secretion via the cAMP-dependent pathway.

Evidence level: This is an in vitro study on adenoma cells, not a clinical trial in healthy individuals. The applicability to normal physiological supplementation is uncertain. Evidence is preliminary and cell-model based.

Vitamin E

Scientific Evidence:

Vitamin E from the diet supports the function of the pituitary gland by protecting it from damage. As an antioxidant, vitamin E is tasked with preventing oxidative damage — damage that occurs at a cellular level and prevents proper cell function. One study, published in the Journal of Clinical Biochemistry and Nutrition in 2009, reported that vitamin E helps combat oxidative damage to the pituitary gland, helping delay age-related damage to the gland.

Evidence level: Limited to a single published animal or in vitro study. No robust clinical trials have specifically evaluated vitamin E supplementation's impact on human pituitary hormone output.

B Vitamins (B6, B12, and the B Complex)

Scientific Evidence:

According to a 2025 review, deficiencies in B vitamins and vitamin C may affect the function of the HPA axis, adrenal glands, and endocrine system. The authors recommend eating a diet high in vitamins C, E, and B, as these antioxidants may help manage cortisol levels and support adrenal function. Vitamin B6 is involved in the synthesis of several neurotransmitters and hormones, including serotonin, dopamine, and melatonin, and may also play a role in supporting adrenal gland function.

Evidence level: Observational and review-level evidence. No direct randomized controlled trials have established that B vitamin supplementation in non-deficient individuals produces measurable improvements in pituitary hormone levels.

Vitamin C

Scientific Evidence:

As an antioxidant, vitamin C helps protect the pituitary gland and other endocrine organs from oxidative stress. Vitamin C is recommended in a diet high in antioxidants, as it may help manage cortisol levels and support adrenal function.

Evidence level: Primarily mechanistic and review-based. Human clinical trial evidence targeting vitamin C supplementation and pituitary-specific outcomes is lacking.

Zinc

Scientific Evidence:

Selenium and iodine are the two central trace elements for the homeostasis of thyroid hormones, but additional trace elements such as iron, zinc, and copper are also involved. Plasma zinc was the micronutrient that was most influential for hormone concentrations, being positively associated with T3, T4, as well as TSH in one observational study of pregnant women. Processing of TRH precursor peptides in rat brain and pituitary is zinc dependent, according to research published in Peptides (1991), suggesting a role for zinc in hypothalamic-pituitary axis signaling. The structure of nuclear thyroid hormone receptors contains zinc ions, crucial for the functional properties of the protein.

Evidence level: Observational human data and animal/molecular studies support zinc's involvement in pituitary-thyroid axis signaling. Clinical interventional trials specifically targeting pituitary hormone output through zinc supplementation in replete populations are limited.

Selenium and Iodine

Scientific Evidence:

The adequate availability and metabolism of three essential trace elements — iodine, selenium, and iron — provide the basic requirements for the function and action of the thyroid hormone system in humans. Disbalances between the thyroidal content of these elements challenge the negative feedback regulation of the hypothalamus–pituitary–thyroid periphery axis, causing or facilitating common diseases related to disturbed thyroid hormone status such as autoimmune thyroid disease and metabolic disorders.

Selenium is a key micronutrient involved in thyroid development, hormone synthesis, antioxidant defense, and immune regulation, especially during pregnancy and childhood. Particularly in early infancy, when the hypothalamic–pituitary–thyroid axis is still immature, thyroid dysfunction can lead to irreversible neurodevelopmental damage and growth delays, emphasizing the need for adequate thyroid function during this highly vulnerable stage.

Evidence level: Well-established in nutritional science that iodine and selenium deficiency disrupts hypothalamic-pituitary-thyroid axis feedback. Clinical consequences of deficiency (e.g., elevated TSH, altered T3/T4) are well documented. Evidence for supplementation benefit is strongest in deficiency states; benefit in replete individuals is less clear.

Omega-3 Polyunsaturated Fatty Acids (EPA and DHA)

Scientific Evidence:

According to a 2024 review, omega-3s may help support the hypothalamic–pituitary–adrenal (HPA) axis by regulating cortisol production, commonly referred to as the stress hormone. They may also inhibit the production of inflammatory compounds.

Preclinical and clinical data have reported that low plasma omega-3 PUFA levels have a correlation with higher corticotropin-releasing factor (CRF) and higher plasma cortisol, while supplementation with omega-3 PUFAs can reduce CRF expression and corticosterone secretion. EPA and DHA regulate the HPA axis by mitigating excessive cortisol production, which is often associated with stress responses and mental health disorders like depression and anxiety.

Studies have shown that omega-3 PUFAs, including docosahexaenoic acid (DHA), might have beneficial effects on somatic and mental health, potentially partly due to their mitigating effects on three major biological stress systems: the immune-inflammatory system, the hypothalamic-pituitary-adrenal axis, and the autonomic nervous system. An examination in 2,724 participants from the Netherlands Study of Depression and Anxiety measured plasma n-3 PUFA and DHA. Higher levels of all three inflammation markers, evening cortisol, and heart rate were significantly negatively associated with n-3 PUFA. A higher number of markers indicative of inflammation and hyperactive HPA-axis was found in persons with lower n-3 PUFA levels.

Evidence level: Moderate observational and some clinical trial evidence supports the role of omega-3 PUFAs in modulating the HPA axis and cortisol levels. Most clinical studies are small and conducted in specific populations (e.g., patients with depression or burnout). Evidence in healthy populations is less established.

Herbs and Natural Ingredients: Traditional Use and Scientific Evidence

Ashwagandha (Withania somnifera)

Traditional Use:

Ashwagandha (Withania somnifera), a well-established herb in Ayurvedic medicine, is increasingly researched for its adaptogenic properties and regulatory roles in neuroimmune processes. Ashwagandha, an adaptogenic Ayurvedic herb, has been often used to combat and reduce stress and thereby enhance general wellbeing. In traditional Ayurvedic practice, it was classified as a "Rasayana" — a rejuvenating class of herbs — and used as a tonic for vitality, sexual function, and stress resilience.

Scientific Evidence:

Bioactive compounds in ashwagandha such as withanolides, sitoindosides, and alkaloids modulate the hypothalamic-pituitary-adrenal (HPA) axis, inhibit NF-κB, induce Nrf2 activation, and affect GABAergic signaling, collectively contributing to its anti-inflammatory, antioxidant, and anxiolytic actions.

In an eight-week, prospective, randomized, double-blind, placebo-controlled study, the stress-relieving effect of ashwagandha root extract was investigated in stressed healthy adults. A significant reduction in perceived stress scores was observed with ashwagandha 250 mg/day and 600 mg/day. Serum cortisol levels reduced with both 250 mg/day and 600 mg/day doses.

These findings suggest that ashwagandha's stress-relieving effects may occur via its moderating effect on the hypothalamus-pituitary-adrenal axis. However, further investigation utilizing larger sample sizes, diverse clinical and cultural populations, and varying treatment dosages is needed to substantiate these findings.

One case report found low basal cortisol levels and a suboptimal response to the ACTH stimulation test, indicative of adrenal insufficiency, in a patient with consistent daily use of approximately 950 mg of ashwagandha for over a year. This illustrates that chronically high-dose ashwagandha use warrants monitoring.

Reviews emphasize methodological shortcomings in ashwagandha research, such as heterogeneity in the preparation of extracts, small sample sizes, variability in endpoints, and possible funding-related biases.

Evidence level: Moderate clinical evidence from small-to-medium double-blind RCTs supports HPA axis modulation and cortisol reduction. Evidence for direct pituitary effects specifically (as opposed to downstream adrenal effects) is indirect. Larger, independent clinical trials are needed.

Maca (Lepidium meyenii / Lepidium peruvianum)

Traditional Use:

Maca is traditionally employed in the Andean region for its supposed fertility benefits. Peruvians have used the root of Lepidium meyenii for centuries as both a nutritious food and fertility medicine for humans and animals.

Scientific Evidence:

Maca's chemical composition varies due to ecotypes, growth conditions, and post-harvest processing, contributing to its intricate phytochemical profile, including macamides, macaenes, and glucosinolates, among other components.

One animal study demonstrated that maca uniquely enhances LH serum levels of pituitary hormones in female rats during the pro-oestrus LH surge and acts in a pharmacological, dose-dependent manner. These findings support the traditional use of maca to enhance fertility and suggest a potential molecular mechanism responsible for its effects. This study used female Sprague-Dawley rats fed maca powder for 7 weeks — it is a preclinical finding.

In a double-blind, randomized, placebo-controlled crossover clinical study in early-postmenopausal women, Maca-GO acted as a toner of hormonal processes along the Hypothalamus-Pituitary-Ovarian axis, balanced hormone levels, and relieved symptoms of menopausal discomfort (hot flushes and night sweating in particular), exhibiting a distinctive function peculiar to adaptogens, providing an alternative non-hormonal plant option to reduce dependence on hormone therapy programs.

Maca also significantly stimulated production of estradiol (E2) along the hypothalamus-pituitary-ovaries axis. Simultaneously, authors found suppression of blood follicle-stimulating hormone (FSH), luteinizing hormone (LH), triiodothyronine (T3), cortisol, and adrenocorticotropic hormone (ACTH) levels, along with an increase in blood iron and bone density index.

In a double-blind, randomized, placebo-controlled pilot trial in 20 men aged 20–40 supplied with milled maca hypocotyl (1.75 g/day) for 12 weeks, sperm concentration and motility showed rising trends compared to placebo, even though hormone levels did not change significantly after 12 weeks of trial.

A hypothesis exists that maca exerts a hormonal balancing effect through its alkaloids, which act on the hypothalamus-pituitary-adrenal (HPA) axis, but this has not been confirmed. More recent evidence points to a probably synergistic mechanism for its effects on the HPA axis.

Evidence level: Preliminary-to-moderate. Some small RCTs in specific populations (postmenopausal women, men with subfertility) show effects on pituitary-regulated hormones. Evidence for mechanism is not yet established. Sample sizes in most studies are small, and replication in diverse populations is limited.

Factors That Support Normal Pituitary Function

An individual can survive without their pituitary gland as long as they take medication to replace the pituitary hormones that are missing. The pituitary gland hormones are very important for maintaining several bodily functions, and an untreated lack of all the pituitary hormones is life-threatening.

Together, the brain and pituitary gland form the neuroendocrine system. This system constantly monitors glands and organs to determine whether to send or to stop the chemical messengers (hormones) that control their functions. Supporting normal pituitary function, as indicated by peer-reviewed sources, involves maintaining adequate levels of essential micronutrients — particularly iodine, selenium, zinc, and vitamins D, A, and the B complex — as deficiencies in these nutrients can disrupt the hypothalamic-pituitary axis. A 2019 review suggests that eating a balanced diet high in polyphenols, such as the Mediterranean diet, may control inflammation and oxidative stress in the hypothalamus. However, further studies are necessary, as experts do not fully understand how polyphenols affect humans.

The deleterious effects of stress are thought to be channeled through dynamic responsiveness of the hypothalamic-pituitary-adrenal (HPA) axis, resulting in increased cortisol secretion by the adrenal cortex in response to stressors. Cortisol initiates numerous physiological changes to compensate for the additional demands, and prolonged overactivation or suppression of the HPA axis may harm both physical and mental health.

References

• Medscape: Pituitary Gland Anatomy: Overview, Gross Anatomy, Microscopic Anatomy
• Cleveland Clinic: Pituitary Gland — What It Is, Function & Anatomy
• Kenhub: Pituitary Gland — Anatomy and Function of the Hypophysis
• OpenStax Anatomy and Physiology 2e: The Pituitary Gland and Hypothalamus
• Barrow Neurological Institute: Pituitary Gland Location and Main Functions
• Wikipedia: Pituitary Gland
• NIH/NCBI — Endotext: Pituitary Diseases in the Tropics
• NIH/NCBI — StatPearls: Hypopituitarism
• NIH/NCBI — StatPearls: Pituitary Gland Imaging
• MedlinePlus: Pituitary Disorders
• Johns Hopkins Medicine: Disorders of the Pituitary Gland
• NIH/NINDS: Pituitary Tumors
• NIH/NICHD: How Do Healthcare Providers Diagnose Pituitary Tumors?
• NIH/NCBI — Endotext: Endocrine Testing Protocols — Hypothalamic Pituitary Adrenal Axis
• American Cancer Society: Tests for Pituitary Tumors
• OHSU Brain Institute: Understanding Pituitary Disorders
• City of Hope: Pituitary Tumor and Diagnosis
• PubMed: Vitamin A and Retinoic Acid Stimulate GH Secretion in Human Pituitary Cells (1996)
• ScienceDirect: Vitamin D Receptor Gene Expression in Human Pituitary Gland
• PubMed: Vitamin D Sites of Action in the Pituitary Studied by Combined Autoradiography-Immunohistochemistry (1988)
• PMC: Vitamin D Interferes with Transactivation of the Growth Hormone Gene
• NIH Grant: Vitamin D3 Regulation of the Hypothalamic-Pituitary-Gonadal Axis
• The Fine Crosstalk Between Vitamin D and Pituitary Gland (Journal of Bone Fragility)
• PMC: Ashwagandha as an Adaptogenic Herb: A Comprehensive Review of Immunological and Neurological Effects (2025)
• PubMed: Adaptogenic and Anxiolytic Effects of Ashwagandha Root Extract in Healthy Adults (2020)
• PubMed: An Investigation into the Stress-Relieving and Pharmacological Actions of an Ashwagandha Extract (2019)
• PMC: From Herbal Hope to Hormonal Havoc — Chronic Ashwagandha Use and HPA Axis Suppression (2025)
• PMC: Exploring the Chemical and Pharmacological Variability of Lepidium meyenii — A Comprehensive Review (2024)
• PMC: Hormone-Balancing Effect of Pre-Gelatinized Organic Maca in Early-Postmenopausal Women (2013)
• PMC: Effect of Lepidium meyenii Walp. on Semen Parameters and Serum Hormone Levels in Healthy Adult Men (2015)
• ScienceDirect: Lepidium meyenii (Maca) Enhances Serum Levels of Luteinising Hormone in Female Rats (2013)
• PMC: Assessment of Joint Impact of Iodine, Selenium, and Zinc Status on Thyroid Hormone Concentrations (2022)
• PMC: The Nutritional Supply of Iodine and Selenium Affects Thyroid Hormone Axis Related Endpoints in Mice (2021)
• PMC: Selenium, Iodine and Iron — Essential Trace Elements for Thyroid Hormone Synthesis and Metabolism (2023)
• PMC: Thyroid Health and Selenium — The Critical Role of Adequate Intake (2025)
• PMC: Possible Antidepressant Mechanisms of Omega-3 Polyunsaturated Fatty Acids Acting on the CNS (2022)
• PMC: Molecular Mechanisms Linking Omega-3 Fatty Acids and the Gut–Brain Axis (2025)
• PubMed: Omega-3 Polyunsaturated Fatty Acid Levels and Dysregulations in Biological Stress Systems (2018)
• ScienceDirect: Omega-3-Polyunsaturated Fatty Acids Reduced Symptoms of Occupational Burnout and Lowered Morning Cortisol (2019)
• Medical News Today: Nutrients for Hypothalamus and Pituitary Gland Production